Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

BiOasis Technologies Inc V.BTI

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  BIOAF

biOasis Technologies Inc is a biopharmaceutical company focused on the delivery of therapeutics across the blood-brain barrier and into the brain tissue. Its focus is to address unmet medical needs with its proprietary Transcend Platform.
Price: $1.18 | Change: +$0.03 | %Change: +2.61%
Volume: 11,500 | Day High/Low: 1.19/1.18 | 52 Week High/Low: 1.50/0.75
View modes: 
0 stars

BIOAF

A BIG yawn in the US. 1000 shares traded. Up 0.006 cents!  rate and reply
2 stars

STOOPID DAYZ J.D

Your silence is deafening?....Was this the whipped cream topped with Grand Marnier for the pumpkin pie?  rate and reply
3 stars

RE:RE:Sir Holler

well what could they do with an advantage? I don't see a to of shares being scooped up , much less crazy volume either . it doesn't make sense, my opinion is if we as shareholders are not getting to...read more
2.5 stars

RE:Sir Holler

As I said, "BTI may have much more information than we were given in the last news release concerning various doseing regimes, and how much of the problem remained in the Scarpa study. Those close to...read more
3 stars

Sir Holler

this is a post from you yesterday...here is a small piece of that post that I cut and will paste right here............................................................"Concerning Hunter's Syndrome, it...read more
3 stars

RE:RE:RE:RE:RE:Tuesdays price action

"the Herceptin news got us red that day, why would anyone be expecting a pop from lsd?" The ability to predict human outcomes with a mouse model when it comes to brain cancer isn't as strong as the...read more
2.5 stars

RE:RE:RE:RE:Tuesdays price action

the Herceptin news got us red that day, why would anyone be expecting a pop from lsd? I was allways under the impression that Herceptin was going to be the bread and butter here  rate and reply
0 stars

RE:RE:RE:Tuesdays price action

If there is gonig to be Tuesday price action for BTI, will there be price action on Monday for BIOAF? I don't know if BIOAF is able to trade when markets for BTI are closed.  rate and reply
3 stars

RE:RE:Tuesdays price action

What are you guys and girls expecting in terms of price appreciation when the market opens based on the news just released (if any at all)? I expect (approximately) the following price appreciation...read more
3 stars

RE:Scarpa

deadpatient:.....in one post you tell us that scarpa is doing cartwheels, and on this one you say he gave an appropriate measured response. in the press release I see an appropriate measured response ...read more
3 stars

RE:RE:Tuesdays price action

the other thing is that rob said this was going to be a very exciting year he hoped, so the next 5 months are , well the next 5 months..... I just think we all have a cwertain expectation here as far...read more
3 stars

RE:Tuesdays price action

not to sound like a basher but , I don't see any action on Tuesday as far as share price goes. there was no action on Herceptin news and I doubt there will be any on hunter syndrome either. it seems...read more
0 stars

Tuesdays price action

What are you guys and girls expecting in terms of price appreciation when the market opens based on the news just released(if any at all)?  Value  rate and reply
4 stars

More evidence that BTI has a universally successful carrier

"This knockout mouse model of Hunter Syndrome (MPS II) showed that the Transcend fusion protein, MTfp-I2S (MTfp-Iduronate-2-sulfatase), was able to cross the blood-brain barrier, reached therapeutic...read more
3.5 stars

RE:RE:more details in the PR

there has to be a reason that we have not received the full data sets on all three studies. I don't believe the reason is that they are trying to hide anything as sir holler wrote earlier, especially...read more
3 stars

RE:more details in the PR

you really have to take a good hard look at what j.d has said all along in regards to deals and things really beginning to snowball with bioasis now more than ever. lovin coal makes another great...read more
4 stars

more details in the PR

just want to remind everyone that if you are filing an IND with the FDA or presenting your findings at a conference you are restricted from publishing all your research findings.  rate and reply
5 stars

Scarpa

I think a man of his standing in this field gave an appropriate and measured response.....The devil in the details will emerge.....I would like J.D and pmriders thoughts on the press release  rate and reply
4 stars

RE:RE:RE:RE:RE:RE:RE:RE:What Hunter Syndrome Could Be Worth:

agreed. we need more clarity from the company. however, their deal with harvard recently is encouraging as if the results were poor, why would harvard come on board?  rate and reply
1 star

RE:RE:RE:RE:RE:RE:What Hunter Syndrome Could Be Worth:

http://www.stockhouse.com/companies/bullboard/v.bti/bioasis-technologies-inc?postid=23983284 Sure below I will explain kayaker, but perhaps you missed the above post of mine. The $225M is really $15M...read more